Announcements Trials
Browse Landscape

Phase

Phase 4 9Phase NA 4Phase 2 4Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastroesophageal Reflux 1Esophagitis 1Barrett Esophagus 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Esomeprazole × Clear all
NCT00216788 2010-03-16

The Effect of Nexium on Transmucosal Esophageal Leak

Main Line Health

Phase 1 Unknown
35 enrolled
Gastrointestinal

Barrett Esophagus, Esophagitis, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡